Liver diseases are increasing globally, marked by conditions like NAFLD, hepatitis, and cirrhosis, leading to a surge in ...

Fatty liver disease is a common health issue. It is often linked to weight and lifestyle. Early detection is key to prevent ...

Objective Non-alcoholic fatty liver disease (NAFLD) is the leading cause of end-stage liver diseases worldwide. Understanding NAFLD prevalence and trends over time at the global, regional and national ...

Maria Palen, who has more than 20,000 followers on Instagram, was in so much pain, that she was unable to complete everyday tasks.

A shocking new study shows a significant connection between type 2 diabetes and liver diseases, highlighting the increased risk for those with obesity. Learn how metabolic dysfunction affects ...

The increasing production and use of bioplastics contribute to the accumulation of bioplastic debris in marine environments. The impact of such debris, particularly when combined with co-occurring ...

Non-alcoholic fatty liver disease (NAFLD) is common, affecting approximately 25% of the general population. The evidence base for the investigation and management of NAFLD is large and growing, but ...

Current and target pathways to a MASH diagnosis. Abbreviations: MASH, metabolic dysfunction-associated steatohepatitis. Credit: The Lancet Regional Health - Europe (2025). DOI: 10.1016/j.lanepe ...

Hospitalizations for hepatorenal syndrome with alcohol-related liver disease increased from 52.8% in 2018 to 59.8% in 2021, then decreased to 56.5% in 2023.

MASH improvement was defined as a decrease of at least 2 points in non-alcoholic fatty liver disease activity score (NAS) or a NAS of 3 points or less. After an end of study biopsy at week 48, 53% ...